{
    "title": "Bristol Myers' profit beats on better-than-feared Revlimid sales",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11706493/Bristol-Myers-profit-beats-better-feared-Revlimid-sales.html",
    "date": "2023-02-02",
    "keywords": [
        "year",
        "company",
        "cancer",
        "quarter",
        "share",
        "erman",
        "revlimid",
        "competition",
        "forecast",
        "decline",
        "co",
        "thursday",
        "drop",
        "drug",
        "generic",
        "wall",
        "street",
        "erosion",
        "note",
        "bristol",
        "momentum",
        "product",
        "portfolio",
        "versus",
        "officer",
        "david",
        "call",
        "companys",
        "drugmaker",
        "effect",
        "exchange",
        "cfo",
        "everybody",
        "blood",
        "thinner",
        "pfizer",
        "inc",
        "immunotherapy",
        "average",
        "revenue",
        "reporting",
        "jersey",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "bradley",
        "perrett",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}